Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)

v3.22.2.2
BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 31, 2022
USD ($)
Integer
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Integer
Sep. 30, 2021
USD ($)
Patents owned by the Company | Integer       96  
Gain on its ILiAD investment   $ 3,727,000   $ 3,727,000  
Gain on ILiAD conversion of convertible note   $ 271,000 $ 271,000
I Li A D Biotechnologies L L C [Member]          
Aggregate investment amount $ 7,000,000        
Patents owned by ILiAD | Integer 62